To evaluate three-phase CT findings of combined hepatocellular and cholangiocarcinomas (cHCC-CCs), with an emphasis on the enhancement pattern.
INTRODUCTION
Primary liver cancers can be histologically divided into two categories, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The HCC accounts for more than 80% and CC accounts for 15% of cases of primary liver cancers (1) . Combined hepatocellular and cholangiocarcinoma (cHCC-CC) is a rare subtype (1.0-4.7%) of liver cancer displaying components of both HCC and CC, but are increasingly recognized due to more extensive sampling of the surgical specimens with immunohistochemical stain (1, 2) .
Since the first description of cHCC-CC was reported by Allen and Lisa (3) in 1949, several pathological classifications of cHCC-CCs have been reported (3) (4) (5) (6) (7) . Based on the classification of World Health Organization (WHO), cHCC-CC is defined as a tumor containing unequivocal, intimately mixed elements of both HCC and CC (8) Of the 11 patients, ten patients (91%) had liver cirrhosis, and were associated with either hepatitis B (n = 8) or alcohol abuse (n = 2). Elevated tumor markers including enhanced levels of alpha-fetoprotein (AFP) (n = 6), carcinoembryonic antigen (CEA) (n = 1), and carbohydrate antigen 19-9 (n = 2) were found in nine patients.
Image Acquisition
Eleven patients underwent three-phase CT during the AP, PVP, and EP imaging. Multidetector CT (MDCT) was performed by using one of the following CT scanners: 16-channel CT scanner (Sensation16; Siemens Medical Solutions, Forchheim, Germany) (n = 3), and 64-channel CT scanner (Sensation 64; Siemens Medical Solutions, Forchheim, Germany) (n = 4).
The remaining four patients were imaged with CT scanners outside our institution: 16-channel CT scanner (Somatom Emotion unit; Siemens Medical Solutions, Erlangen, Germany) (n = 1), and single slice CT scanner (Asteion CT scanner; Toshiba Medical Systems, Tokyo, Japan) (n = 3).
At our institution, the following scanning parameters were 
Image Analysis
Two abdominal radiologists with 25 and 13 years of clinical experience retrospectively analyzed the CT images by consenguishable (8) . Therefore, it might be difficult to make a correct diagnosis about cHCC-CC before surgery. Furthermore, even though the biological features of cHCC-CCs have been reported to be similar to those of HCC rather than CC, the prognosis of patients with cHCC-CCs is poorer than in patients with HCC or CC (9-11). Furthermore, aggressive surgical treatment including lymph node dissection might be essential for successful treatment of cHCC-CCs (11). Thus, it is very important to make preoperative diagnosis of cHCC-CCs.
To the best of our knowledge, there have been only a few reports describing the imaging findings of cHCC-CC using ultrasonography and CT because of its rarity (12-17). Most of the reports have described their CT findings of cHCC-CC, and revealed that they resembled HCC or CC depending on their predominant components of HCC or CC. However, there are no reports that describe the characteristic enhancement pattern of cHCC-CC, particularly about the three phases. The purpose of our study was to evaluate three-phase CT findings of cHCC-CC with an emphasis on the enhancement pattern.
MATERIALS AND METHODS

Patients
The institutional review board of our hospital approved this retrospective study and waived the requirement for informed consent. We performed a computerized search of our hospital's surgical records from January 2001 and March 2011 using the search term "combined hepatocellular and cholangiocarcinoma". This search identified 16 patients with cHCC-CCs during histopathologic examination. Of these patients, five patients were excluded from the present investigation because two patients had collision tumors, which were widely separated or close to each other, and three patients did not undergo threephase CT. The remaining 11 patients (nine men and two wom- Only a few studies have described the resemblance between CT findings of cHCC-CC and HCC or CC depending on the predomince of HCC or CC components (12-17). Previously, it has been reported that a confident diagnosis of cHCC-CC is not possible on the basis of CT findings alone because of the lack of specific imaging characteristics, and it was difficult to differentiate cHCC-CC from HCC or CC based on CT alone 
RESULTS
For the morphologic pattern, the mean diameter of all the tumors was 4.8 cm (range, 1.3 of 11.0 cm) and all of them were located in the right lobe. The tumor shape was round, lobulated, and irregular in six, four, and one tumor, respectively. Ancillary findings such as fibrous capsule, portal vein thrombosis, and bile duct dilatation were found in two, one, and one patient, respectively. of HCC or CC component. Second, the number of cases was too small to obtain statistically significant results. Therefore, we could only suggest the correlation between the enhancement patterns of our cHCC-CCs and their histopathologic characteristics. Third, we could not use the same CT protocols in that they included eight cases using MDCT and three cases using single slice CT, because we collected these rare cases from the past 10 years.
In conclusion, three-phase CT findings of cHCC-CCs were variable, particularly in their enhancement pattern according to the histologic proportion of HCC and CC components. However, cHCC-CC could be considered, when a tumor shows both arterial enhancement and delayed enhancement at three-phase CT.
